Sputnik V have claimed that its vaccine provides longer immunity for 2 years of immunity against corona virus compared to it’s rival Pfizer that only provides protection for 4-5 months. Alexander Gintsburg said that Sputnik V is created on the same genome that was also used for Ebola vaccine which provides longer safety and durability when administered two shots on the 28th day after the dose.
Sputnik V has recorded 96 percent efficacy claimed Gintsburg. Sputnik V is currently in the Phase II-III trials in various countries including India.